Roivant Sciences Ltd
NASDAQ:ROIV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
BM |
|
E
|
EEI Corp
XPHS:EEI
|
PH |
|
H
|
Hallmark Financial Services Inc
XBER:SSB
|
US |
|
CalAmp Corp
OTC:CAMPQ
|
US |
|
TraWell Co SpA
MIL:TWL
|
IT |
|
APM Human Services International Ltd
ASX:APM
|
AU |
|
Orge Enerji Elektrik Taahhut AS
IST:ORGE.E
|
TR |
|
P
|
Phong Phu Pharmaceutical JSC
VN:PPP
|
VN |
|
Genuit Group PLC
LSE:GEN
|
UK |
|
K
|
Kinetik Holdings Inc
NYSE:KNTK
|
US |
|
Sintana Energy Inc
XTSX:SEI
|
CA |
|
A
|
Ampd Ventures Inc
CNSX:AMPD
|
CA |
|
Celsius Holdings Inc
NASDAQ:CELH
|
US |
|
P
|
Philomaxcap AG
F:HBD1
|
DE |
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
US |
|
A
|
Advantis Corp
OTC:ADVT
|
US |
|
H
|
Helix Resources Ltd
ASX:HLX
|
AU |
|
S
|
Suzhou Jinhongshun Auto Parts Co Ltd
SSE:603922
|
CN |
|
V
|
Viva Wine Group AB
STO:VIVA
|
SE |
Wall Street
Price Targets
ROIV Price Targets Summary
Roivant Sciences Ltd
According to Wall Street analysts, the average 1-year price target for
ROIV
is 33.29 USD
with a low forecast of 21.21 USD and a high forecast of 40.95 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ROIV's stock price target?
Price Target
33.29
USD
According to Wall Street analysts, the average 1-year price target for
ROIV
is 33.29 USD
with a low forecast of 21.21 USD and a high forecast of 40.95 USD.
What is Roivant Sciences Ltd's Revenue forecast?
Projected CAGR
184%
For the last 4 years the
compound annual growth rate for
Roivant Sciences Ltd's revenue is
5%.
The projected
CAGR
for the next 4 years is
184%.
